Balsa, José A <br/><br/>
The role of serum osteoprotegerin and receptor-activator of nuclear factor-κB ligand in metabolic bone disease of women after obesity surgery.  [electronic resource] 

 -  Journal of bone and mineral metabolism  Nov 2016 
 - 655-661 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1435-5604 
<br/><br/><label>Standard No.: </label>10.1007/s00774-015-0712-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bariatric Surgery--adverse effects<br/>Biomarkers--blood<br/>Bone Density<br/>Bone Diseases, Metabolic--blood<br/>Female<br/>Humans<br/>Middle Aged<br/>Obesity--blood<br/>Osteocalcin--blood<br/>Osteoprotegerin--blood<br/>Parathyroid Hormone--blood<br/>Pelvic Bones--metabolism<br/>Postoperative Complications--blood<br/>RANK Ligand--blood<br/>Spine--metabolism